McCune-Albright syndrome (MAS) is characterized by the clinical triad
of polyostotic fibrous dysplasia, cafe-au-lait pigmented skin lesions,
and multiple endocrinopathies. The molecular basis of MAS is a mutati
on in G(s)alpha that results in constitutive activation of adenylyl cy
clase in affected tissues. This mutation occurs during early embryogen
esis, and therefore patients with MAS are mosaic. The identification o
f activating mutations of G(s)alpha in liver, heart, and gastrointesti
nal tract of patients with MAS suggests a broader spectrum of clinical
disease than previously appreciated.